ArticleDiabetology & metabolic syndrome2025

Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials.

Kannan Sridharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.